Catalyst Wire Dossier Catalyst Wire Dossier

Selonsertib

selonsertib · Gilead Sciences
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Selonsertib, covering 2019-02-06 to 2022-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease [Phase 2]

See pricing